Phase 1 Extensive-stage Small-cell Lung Cancer Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer

Extensive-stage Small-cell Lung Cancer

Memorial Sloan Kettering Cancer Center24 enrolled7 locationsNCT06807632

Recruiting

Phase 1Phase 2

Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC

Lung CancerExtensive-stage Small-cell Lung Cancer

Sichuan University45 enrolled1 locationNCT06217757